Navigation Links
Zymes’ Water Soluble CoQ10 Decreases Symptoms in Animal Models of Parkinson’s Disease
Date:5/11/2010

HASBROUCK HEIGHTS, N.J., May 11 /PRNewswire/ -- Scientists from Zymes LLC, the University of Windsor (Ontario, Canada) and the National Research Council of Canada presented their research at the 2010 Experimental Biology meetings in Anaheim California on April 28th.  The paper entitled, "Protection of SNpc neurons by water soluble CoQ10 in a paraquat induced rat model of Parkinson's disease: The role of neurotrophic factors," describes a potential treatment for halting the progression of Parkinson's disease in an animal model using Zymes' water soluble CoQ10 (WS-CoQ10) formulation.  

Parkinson's disease (PD) is a neurodegenerative disorder that results from the progressive loss of select neurons in the brain.  Many studies show that mitochondrial dysfunction/oxidative stress is a major contributor to this disease.  An established animal model of paraquat-induced Parkinson's disease was used in this study.  Animals were given Zymes' water soluble CoQ10 in their drinking water with access 24 hours a day pre-treatment (prophylactic) and post-treatment (therapeutic). In these studies, Zymes' water soluble CoQ10 provided significant protection of dopaminergic neurons and a decrease in symptoms.  

"We are very excited about these early stage findings that support the use of Zymes' water soluble CoQ10 to halt the symptoms of Parkinson's disease," said Dr. Shelley Weinstock, Sr. VP of Research and Scientific Affairs.  In addition, in these studies, animals were exposed to the water soluble CoQ10 on a continuous basis in their water, suggesting that small doses, several times a day is a more effective method of administration than larger doses once or twice per day.  More research is needed to determine if Zymes' water soluble CoQ10 may be effective in halting the progression of Parkinson's disease in people.

About Zymes LLC:

Zymes LLC is a bioscience company based in Hasbrouck Heights, NJ that provides innovative solutions to its partners and consumers through proprietary science and technology, enabling new products to enhance the well-being of people. For more information please visit www.zymes.com.


'/>"/>
SOURCE Zymes LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. DuPont Leader: Agricultural Improvements Key to Meeting Growing Food, Water Needs in Africa
2. Florida Water Resources Annual Conference Focuses on Numeric Nutrient and Other Water Issues
3. Waters and DAISO Sign Marketing Agreement for Bulk Process Chromatography Media
4. Life Sciences Venture Capital Funding Overcomes Record Lows, Outpaces Other Sectors, According to PricewaterhouseCoopers
5. Water Filtration and Liquid Separation Training by the American Filtration and Separations Society.
6. Biomedical Industry Jobs Critical to Californias Economic Recovery, Finds California Healthcare Institute and PricewaterhouseCoopers
7. Microbix And Therapure Biopharma Form Partnership To Expand Water-Based Supplies To The Pharma Industry
8. Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010
9. Waters Ships First Units of SYNAPT G2 Mass Spectrometer
10. Water droplets direct self-assembly process in thin-film materials
11. Safety in Drinking Water? Monitoring for Radioactive Contaminants Only Required Every Three, Six, or Nine Years per Federal Law
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... April 21, 2017 , ... Having worked on the design ... is pleased to introduce it to top lab design architects from around the country ... and VP of Industrial Design and Engineering Greg Casey will be at the show, ...
(Date:4/21/2017)... ... 21, 2017 , ... The AMA is happy to announce that $48,000 in ... nation. The scholarships are created through funds donated by model aviation organizations and individuals, ... by the AMA Scholarship Committee, which is made up of model aviation pilots and ...
(Date:4/20/2017)... ... April 20, 2017 , ... As part ... will explore challenging patient cases when screening for direct oral anticoagulant. When patients ... a need for bridging parental anticoagulation especially for those at high risk of ...
(Date:4/20/2017)... SANTA BARBARA, CALIFORNIA (PRWEB) , ... April 20, 2017 , ... ... process optimization firm for the life sciences and healthcare industries, is pleased to announce ... of the new established USDM subsidiary “USDM Europe GmbH” based in Germany. , ...
Breaking Biology Technology:
(Date:4/11/2017)... Research and Markets has announced the addition ... their offering. ... tracking market to grow at a CAGR of 30.37% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:4/11/2017)... -- NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" ... of independent Directors Mr. Robin D. Richards and ... furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer ... guidance and benefiting from their considerable expertise as we move ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
Breaking Biology News(10 mins):